These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 28898714)

  • 21. Evaluation of an mHealth-enabled hierarchical diabetes management intervention in primary care in China (ROADMAP): A cluster randomized trial.
    Jia W; Zhang P; Zhu D; Duolikun N; Li H; Bao Y; Li X;
    PLoS Med; 2021 Sep; 18(9):e1003754. PubMed ID: 34547030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prevalence of retinopathy in patients with type 1 diabetes treated with education-based intensified insulin therapy and its association with parameters of glucose control.
    Hatz K; Minder AE; Lehmann R; Drescher T; Gerendas B; Schmidt-Erfurth U; Kaider A; Pruente C; Zulewski H
    Diabetes Res Clin Pract; 2019 Feb; 148():234-239. PubMed ID: 30684505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
    Beck RW; Riddlesworth T; Ruedy K; Ahmann A; Bergenstal R; Haller S; Kollman C; Kruger D; McGill JB; Polonsky W; Toschi E; Wolpert H; Price D;
    JAMA; 2017 Jan; 317(4):371-378. PubMed ID: 28118453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes: The SURPASS-5 Randomized Clinical Trial.
    Dahl D; Onishi Y; Norwood P; Huh R; Bray R; Patel H; Rodríguez Á
    JAMA; 2022 Feb; 327(6):534-545. PubMed ID: 35133415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Poor glycemic control is associated with significant increase in major limb amputation and adverse events in the 30-day postoperative period after infrainguinal bypass.
    McGinigle KL; Kindell DG; Strassle PD; Crowner JR; Pascarella L; Farber MA; Marston WA; Arya S; Kalbaugh CA
    J Vasc Surg; 2020 Sep; 72(3):987-994. PubMed ID: 32139308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetes in urban African Americans. III. Management of type II diabetes in a municipal hospital setting.
    Ziemer DC; Goldschmid MG; Musey VC; Domin WS; Thulé PM; Gallina DL; Phillips LS
    Am J Med; 1996 Jul; 101(1):25-33. PubMed ID: 8686711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of a Collaborative Care Model on Depressive Symptoms and Glycated Hemoglobin, Blood Pressure, and Serum Cholesterol Among Patients With Depression and Diabetes in India: The INDEPENDENT Randomized Clinical Trial.
    Ali MK; Chwastiak L; Poongothai S; Emmert-Fees KMF; Patel SA; Anjana RM; Sagar R; Shankar R; Sridhar GR; Kosuri M; Sosale AR; Sosale B; Rao D; Tandon N; Narayan KMV; Mohan V;
    JAMA; 2020 Aug; 324(7):651-662. PubMed ID: 32809002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Supported Telemonitoring and Glycemic Control in People with Type 2 Diabetes: The Telescot Diabetes Pragmatic Multicenter Randomized Controlled Trial.
    Wild SH; Hanley J; Lewis SC; McKnight JA; McCloughan LB; Padfield PL; Parker RA; Paterson M; Pinnock H; Sheikh A; McKinstry B
    PLoS Med; 2016 Jul; 13(7):e1002098. PubMed ID: 27458809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased risk of cardiovascular mortality by strict glycemic control (pre-procedural HbA1c < 6.5%) in Japanese medically-treated diabetic patients following percutaneous coronary intervention: a 10-year follow-up study.
    Funamizu T; Iwata H; Nishida Y; Miyosawa K; Doi S; Chikata Y; Shitara J; Endo H; Wada H; Naito R; Ogita M; Dohi T; Kasai T; Okazaki S; Isoda K; Miyauchi K; Daida H
    Cardiovasc Diabetol; 2020 Feb; 19(1):21. PubMed ID: 32070335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The status of glycemic control: A cross-sectional study of outpatients with type 2 diabetes mellitus across primary, secondary, and tertiary hospitals in the Jiangsu province of China.
    Bi Y; Zhu D; Cheng J; Zhu Y; Xu N; Cui S; Li W; Cheng X; Wang F; Hu Y; Shen S; Weng J
    Clin Ther; 2010 May; 32(5):973-83. PubMed ID: 20685506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liraglutide hospital discharge trial: A randomized controlled trial comparing the safety and efficacy of liraglutide versus insulin glargine for the management of patients with type 2 diabetes after hospital discharge.
    Pasquel FJ; Urrutia MA; Cardona S; Coronado KWZ; Albury B; Perez-Guzman MC; Galindo RJ; Chaudhuri A; Iacobellis G; Palacios J; Farias JM; Gomez P; Anzola I; Vellanki P; Fayfman M; Davis GM; Migdal AL; Peng L; Umpierrez GE
    Diabetes Obes Metab; 2021 Jun; 23(6):1351-1360. PubMed ID: 33591621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
    Weng J
    J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Insulin Glargine Up-titration vs Insulin Degludec/Liraglutide on Glycated Hemoglobin Levels in Patients With Uncontrolled Type 2 Diabetes: The DUAL V Randomized Clinical Trial.
    Lingvay I; Pérez Manghi F; García-Hernández P; Norwood P; Lehmann L; Tarp-Johansen MJ; Buse JB;
    JAMA; 2016 Mar; 315(9):898-907. PubMed ID: 26934259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial.
    Lind M; Polonsky W; Hirsch IB; Heise T; Bolinder J; Dahlqvist S; Schwarz E; Ólafsdóttir AF; Frid A; Wedel H; Ahlén E; Nyström T; Hellman J
    JAMA; 2017 Jan; 317(4):379-387. PubMed ID: 28118454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of professional continuous glucose monitoring as an adjuvant educational tool for improving glycemic control in patients with type 2 diabetes.
    Rivera-Ávila DA; Esquivel-Lu AI; Salazar-Lozano CR; Jones K; Doubova SV
    BMC Endocr Disord; 2021 Apr; 21(1):79. PubMed ID: 33888117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of inpatient diabetes transitions of care consult on glycemic control.
    Powers A; Winder M; Maurer M; Brittain K
    Patient Educ Couns; 2020 Jun; 103(6):1255-1257. PubMed ID: 32014273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Preoperative Diabetes Management on Glycemic Control and Clinical Outcomes After Elective Surgery.
    Garg R; Schuman B; Bader A; Hurwitz S; Turchin A; Underwood P; Metzger C; Rein R; Lortie M
    Ann Surg; 2018 May; 267(5):858-862. PubMed ID: 28549013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term follow-up of a randomized controlled trial of a text-message diabetes self-management support programme, SMS4BG.
    Dobson R; Whittaker R; Jiang Y; McNamara C; Shepherd M; Maddison R; Cutfield R; Khanolkar M; Murphy R
    Diabet Med; 2020 Feb; 37(2):311-318. PubMed ID: 31722130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving access to HbA1c in sub-Saharan Africa (IA3) cohort: cohort profile.
    Balde N; Camara A; Sobngwi-Tambekou J; Balti EV; Tchatchoua A; Fezeu L; Limen S; Ngamani S; Ngapout S; Kengne AP; Sobngwi E
    Pan Afr Med J; 2017; 27():275. PubMed ID: 29187944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ROSSO-in-praxi-international: long-term effects of self-monitoring of blood glucose on glucometabolic control in patients with type 2 diabetes mellitus not treated with insulin.
    Kempf K; Tankova T; Martin S
    Diabetes Technol Ther; 2013 Jan; 15(1):89-96. PubMed ID: 23194054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.